9-Acetoxy-2,7,12,17-tetrakis-(β-methoxyethyl)-porphycene(ATMPn), a novel photosensitizer for photodynamic therapy: Uptake kinetics and intracellular localization

Journal of Photochemistry and Photobiology B: Biology

Volumn 34, Issue 1, 1996, Pages 67-72

  Szeimies, Rolf Markus ^a   Karrer, Sigrid ^a   Abels, Christoph ^a   Steinbach, Pia ^a   Fickweiler, Sonja ^a   Messmann, Helmut ^a   Bäumler, Wolfgang ^a   Landthaler, Michael ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Acetoxy tetrakis ( methoxyethyl) porphycene; ATMPn; Confocal laser scan microscopy; Flow cytometry analysis; Fluorescence; Photodynamic therapy

Indexed keywords

9 ACETOXY 2,7,12,17 TETRAKIS(BETA METHOXYETHYL)PORPHYCENE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DISTRIBUTION; DRUG UPTAKE; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; KERATINOCYTE; MITOCHONDRION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CELL; TEMPERATURE SENSITIVITY;

NOTOLABRUS CELIDOTUS;

EID: 0030175204     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/1011-1344(95)07275-6     Document Type: Article

References (33)

1. [1] D.V. Ash and S.B. Brown, New drugs and future developments in photodynamic therapy, Eur. J. Cancer, 29A (1993) 1781-1783.
2. [2] H. Lui and R.R. Anderson, Photodynamic therapy in dermatology, Arch. Dermatol., 128 (1992) 1631-1636.
3. [3] H.I. Pass, Photodynamic therapy in oncology: mechanism and clinical use, J. Natl. Cancer Inst., 85 (1993) 443-456.
4. [4] R.S. Wooten, K.C. Smith, D.A. Ahlquist, S.A. Muller and R.K. Balm, Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative, Lasers Surg. Med., 8 (1988) 294-300.
5. [5] J.C. Kennedy and R.H. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B: Biol., 14 (1992) 275-292.
6. [6] O. Santoro, G. Bandieramonte, E. Melloni, R. Marchesini, F. Zunino, P. Lepera and G. De Palo, Photodynamic therapy by topical mesotetraphenylporphine-sulfonate tetrasodium salt administration in superficial basal cell carcinomas, Cancer Res., 50 (1990) 4501-4503.
7. [7] P. Wolf, E. Rieger and H. Kerl, Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid, J. Am. Acad. Dermatol., 28 (1993) 17-21.
8. [8] T.J. Dougherty, M.T. Cooper and T.S. Mang, Cutaneous phototoxic occurrences in patients receiving photofrin, Lasers Surg. Med., 10 (1990) 485-488.
9. [9] J.C. Kennedy, R.H. Pottier and D.C. Pross, Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience, J. Photochem. Photobiol. B: Biol., 6 (1990) 143-148.
10. [10] H. Lui, S. Salasche, N. Kollias, J. Wimberly, T. Flotte, D. McLean and R.R. Anderson, Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study, Arch. Dermatol., 131 (1995) 737-747.
11. [11] S. Kimel, V. Gottfried, R. David and C. Averbuj, In vivo uptake and photodynamic activity of porphycenes, Proc. SPIE, 2078 (1994) 205-210.
12. [12] A. Aicher, K. Miller, E. Reich and R. Hautmann, Photosensitization of human bladder cancer cells in vitro by 9-acetoxy-tetra-n-propylporphycene (ATPPn) bound to liposomes from soya phosphatidylcholine, Opt. Eng., 32 (1993) 342-346.
13. [13] E. Vogel, M. Köcher, H. Schmickler and J. Lex, Porphycene - a novel porphin isomer, Angew. Chem., 98 (1986) 262-264.
14. [14] P.F. Aramendia, R.W. Redmond, S. Nonell, W. Schuster, S.E. Braslavsky, K. Schaffner and E. Vogel, The photophysical properties of porphycenes: potential photodynamic therapy agents, Photochem. Photobiol., 44 (1986) 555-559.
15. [15] C. Richert, J.M. Wessels, M. Müller, M. Kisters, T. Benninghaus and A.E. Goetz, Photodynamic antitumor agents: β-methoxyethyl groups give access to functionalized porphycenes and enhance cellular uptake and activity, J. Med. Chem., 37 (1994) 2792-2807.
16. [16] S. Karrer, in preparation.
17. [17] R.M. Szeimies, R. Hein, W. Bäumler, A. Heine and M. Landthaler, Possible new incoherent lamp for photodynamic treatment of superficial skin lesions, Acta Dermatol. Venereol. (Stockholm), 74 (1994) 117-119.
18. [18] P. Boukamp, R.T. Petrussevska, D. Breitkrutz, J. Hornung, A. Markham and N.E. Fusenig, Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line, J. Cell Biol., 106 (1988) 761-771.
19. [19] L.V. Johnson, M.L. Walch, B.J. Bockus and L.B. Chen, Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy, J. Cell Biol., 88 (1981) 526-535.
20. [20] K.W. Woodburn, N.J. Vardaxis, J.S. Hill, A.H. Kaye and D.R. Phillips, Subcellular localization of porphyrins using confocal laser scanning microscopy, Photochem. Photobiol., 54 (1991) 725-732.
21. [21] C. Abels, in preparation.
22. [22] P.M. Armenante, D. Kim and W.N. Duran, Experimental determination of the linear correlation between in vivo TV fluorescence intensity and vascular and tissue FITCDX concentrations, Microvasc. Res., 42 (1991) 198-208.
23. [23] M. Leunig, C. Richert, F. Gamarra, W. Lumper, E. Vogel, D. Jocham and A.E. Goetz, Tumour localisation kinetics of photofrin and three synthetic porphyrinoids in an amelanotic membrane of the hamster, Br. J. Cancer, 68 (1993) 225-234.
24. 4), Lasers Med. Sci., 9 (1994) 111-118.
25. [25] E.M. Muir and D.E. Bowyer. Dependence of fluid-phase pinocytosis in arterial smooth-muscle cells on temperature, cellular ATP concentration and the cytoskeletal system, Biochem. J., 216 (1983) 467-473.
26. [26] J. Moan and T. Christensen, Photodynamic inactivation of cancer cells in vitro. Effect of irradiation temperature and dose fractionation, Cancer Lett., 6 (1981) 331-335.
27. [27] S. Iinuma, S.S. Farshi, B. Ortel and T. Hasan, A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin, Br. J. Cancer, 70 (1994) 21-28.
28. [28] M.W. Berns, A. Dahlman, F.M. Johnson, R. Burns, D. Sperling, M. Guiltanan, A. Siemens, R. Walter, N. Wright, M. Hammer-Wilson and A. Wile, In vitro cellular effects of hematoporphyrin derivative, Cancer Res., 42 (1982) 2325-2329.
29. [29] K.W. Woodburn, N.J. Kaye, A.A. Reiss and D.R. Phillips, Evaluation of porphyrin characteristics required for photodynamic therapy, Photochem. Photobiol., 55 (1992) 697-704.
30. [30] J. Moan, K. Berg, H.B. Steen, T. Warloe and K. Madslien, Fluorescence and photodynamic effects of phthalocyanines and porphyrins in cells, in B.W. Henderson and T.J. Dougherty (eds.), Photodynamic Therapy, New York, 1992, pp. 19-35.
31. [31] G.G. Miller, K. Brown, R.B. Moore, Z.J. Diwu, J. Liu, L. Huang, J.W. Lown, D.A. Begg, V. Chlumecky, J. Tulip and M.S. McPhee, Uptake kinetics and intracellular localization of hypocrellin photosensitizers for photodynamic therapy: a confocal microscopy study, Photochem. Photobiol., 61 (1995) 632-638.
32. [32] R.W. Horobin and R. Rashid, Interactions of molecular probes with living cells and tissues. Part 1. Some general mechanistic proposals, making use of a simplistic Chinese box model, Histochemistry, 94 (1990) 205-209.
33. [33] R. Rashid and R.W. Horobin, Interaction of molecular probes with living cells and tissues. Part 2. A structure-activity analysis of mitochondrial staining by cationic probes, and a discussion of the synergistic nature of image-based and biochemical approaches, Histochemistry, 94 (1990) 303-308.